Grant

Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

Open

An NIH grant supporting early-career scientists transitioning to entrepreneurship via STTR Phase I and Fast-Track applications. In addition to R&D funding, it provides entrepreneurial training, mentoring, and career development.

See your fit

Key facts

Organiser
National Institutes of Health
Deadline
January 5, 2027
Cycles
Forecasted Cycle · deadline January 5, 2027
Opens
November 5, 2026
Amount
Grant
Open to
United States
Sectors
Biotech, Healthtech

3 details are locked

See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.

See your fit

Key questions about Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

Who can apply to Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)?

Eligible locations: United States. The company must be incorporated in United States. Only startups in these sectors qualify: Biotech and Healthtech. Other requirements: PI must never have been an independent PD/PI on NIH/CDC/peer-reviewed research grant; PI must be a U.S. Citizen or Lawful Permanent Resident; Key personnel must include a mentor with measurable effort committed.

When is the Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) deadline?

The Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) deadline is January 5, 2027. Upcoming cycles: Forecasted Cycle · deadline January 5, 2027. Applications opened on November 5, 2026.

See more grants in United States

Other programs in this category

Verified on November 17, 2026 against the official page.